ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)

SHA:603976 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	140.08	108.9	187.62	212.43	392.17	269.29
Trading Asset Securities	150.43	140.58	250.11	159.06	254.76	-
Cash & Short-Term Investments	290.51	249.48	437.73	371.49	646.93	269.29
Cash Growth	-26.13%	-43.01%	17.83%	-42.58%	140.23%	-26.87%
Accounts Receivable	313.57	364.58	397.91	355.53	298.37	226.05
Other Receivables	4.39	4.15	5.51	20.26	2.86	2.98
Receivables	317.96	368.73	403.42	375.8	301.23	229.03
Inventory	258.86	250.48	197.14	209.43	190.5	151.27
Other Current Assets	9.58	7.17	12.87	35.03	12.45	13.87
Total Current Assets	876.92	875.86	1,051	991.75	1,151	663.46
Property, Plant & Equipment	802.64	859.67	919.49	909.85	665.86	552.91
Long-Term Investments	0.05	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	38.58	39.36	40.41	41.6	42.98	41.87
Long-Term Deferred Tax Assets	9.23	8.82	12.65	1.13	5.89	2.08
Long-Term Deferred Charges	1.5	2.23	2.74	3.9	4.27	4.98
Other Long-Term Assets	162.6	170.82	16.38	59.41	90.33	59.24
Total Assets	1,892	1,957	2,043	2,008	1,960	1,325
Accounts Payable	196.74	240.47	313.88	296.65	278.36	197.43
Accrued Expenses	10.13	22.81	23.82	20.68	26.4	16.58
Short-Term Debt	-	-	30	60	50	49.73
Current Portion of Leases	0.02	0.06	0.2	0.37	0.32	-
Current Income Taxes Payable	4.23	0.92	3.3	0.98	13.28	1.52
Current Unearned Revenue	5.08	3.39	4.61	6.77	6.76	6.4
Other Current Liabilities	5.29	2.43	3.63	4.22	3.06	5.77
Total Current Liabilities	221.49	270.08	379.44	389.66	378.18	277.43
Long-Term Debt	440.55	431.99	416.25	399.27	382.32	-
Long-Term Leases	0.03	0.03	0.06	0.54	0.91	-
Long-Term Unearned Revenue	26.8	31.3	31.61	28.63	30.72	6.77
Long-Term Deferred Tax Liabilities	-	-	-	5.37	2.4	-
Total Liabilities	688.88	733.4	827.37	823.47	794.53	284.2
Common Stock	151.2	151.2	151.2	151.2	151.2	151.2
Additional Paid-In Capital	555.71	555.63	555.63	555.63	555.59	555.54
Retained Earnings	471.37	492.22	484.34	453.03	434.82	333.66
Comprehensive Income & Other	24.34	24.35	24.35	24.35	24.35	-
Shareholders' Equity	1,203	1,223	1,216	1,184	1,166	1,040
Total Liabilities & Equity	1,892	1,957	2,043	2,008	1,960	1,325
Total Debt	440.61	432.08	446.51	460.17	433.55	49.73
Net Cash (Debt)	-150.1	-182.6	-8.78	-88.68	213.38	219.56
Net Cash Growth	-	-	-	-	-2.81%	-40.38%
Net Cash Per Share	-1.01	-1.20	-0.06	-0.59	1.42	1.45
Filing Date Shares Outstanding	151.2	151.2	151.2	151.2	151.2	151.2
Total Common Shares Outstanding	151.2	151.2	151.2	151.2	151.2	151.2
Working Capital	655.43	605.78	671.72	602.08	772.92	386.03
Book Value Per Share	7.95	8.09	8.04	7.83	7.71	6.88
Tangible Book Value	1,164	1,184	1,175	1,143	1,123	998.53
Tangible Book Value Per Share	7.70	7.83	7.77	7.56	7.43	6.60
Buildings	-	466.94	467.67	362.71	359.42	215.07
Machinery	-	902.78	926.75	734.29	608.03	361.56
Construction In Progress	-	52.03	10.97	198.58	20.21	251.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.